Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation

Molecular Immunology

Volumn 48, Issue 15-16, 2011, Pages 1753-1761

  Lundequist, Anders ^a   Calounova, Gabriela ^a   Wensman, Helena ^a   Rönnberg, Elin ^a   Pejler, Gunnar ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

IgE receptor cross linking; Mast cells; Nr4a; Nuclear receptors; Protein kinase C

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; CALCIUM IONOPHORE; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER RECEPTOR HOMOLOG 1; NUCLEAR PROTEIN; NUCLEAR RECEPTOR NR3C2; NUCLEAR RECEPTOR NR4A3; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; MAST CELLS; MICE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MURINAE;

EID: 80051932743     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.04.017     Document Type: Article

References (38)

1. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 2001, 81:1269-1304.
2. Beaudry G., Langlois M.C., Weppe I., Rouillard C., Levesque D. Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J. Neurochem. 2000, 75:1694-1702.
3. Blank U., Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 2004, 25:266-273.
4. Bonta P.I., van Tiel C.M., Vos M., Pols T.W., van Thienen J.V., Ferreira V., Arkenbout E.K., Seppen J., Spek C.A., van der Poll T., Pannekoek H., de Vries C.J. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2288-2294.
5. Boyce J.A. Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol. Rev. 2007, 217:168-185.
6. Daeron M., Sterk A.R., Hirata F., Ishizaka T. Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J. Immunol. 1982, 129:1212-1218.
7. de Vries C.J., van Achterberg T.A., Horrevoets A.J., ten Cate J.W., Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J. Biol. Chem. 2000, 275:23939-23947.
8. Duelli A., Rönnberg E., Waern I., Ringvall M., Kolset S.O., Pejler G. Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases. J. Immunol. 2009, 183:7073-7083.
9. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005, 6:135-142.
10. Giguere V. Orphan nuclear receptors: from gene to function. Endocr. Rev. 1999, 20:689-725.
11. Glass C.K., Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 2010, 10:365-376.
12. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol. 2008, 9:1215-1223.
13. Kim S.O., Ono K., Tobias P.S., Han J. Orphan nuclear receptor Nur77 is involved in caspase-independent macrophage cell death. J. Exp. Med. 2003, 197:1441-1452.
14. Liu D., Jia H., Holmes D.I., Stannard A., Zachary I. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler. Thromb. Vasc. Biol. 2003, 23:2002-2007.
15. Liu Z.G., Smith S.W., McLaughlin K.A., Schwartz L.M., Osborne B.A. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 1994, 367:281-284.
16. Lundequist A., Pejler G. Biological implications of preformed mast cell mediators. Cell. Mol. Life Sci. 2011, 68:965-975.
17. Maheux J., Ethier I., Rouillard C., Levesque D. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action. J. Pharmacol. Exp. Ther. 2005, 313:460-473.
18. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
19. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 2004, 4:787-799.
20. Martinez-Gonzalez J., Badimon L. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc. Res. 2005, 65:609-618.
21. Martinez-Gonzalez J., Rius J., Castello A., Cases-Langhoff C., Badimon L. Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ. Res. 2003, 92:96-103.
22. Maxwell M.A., Muscat G.E. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal. 2006, 4:e002.
23. Mullican S.E., Zhang S., Konopleva M., Ruvolo V., Andreeff M., Milbrandt J., Conneely O.M. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat. Med. 2007, 13:730-735.
24. Murphy T.R., Legere H.J., Katz H.R. Activation of protein kinase D1 in mast cells in response to innate, adaptive, and growth factor signals. J. Immunol. 2007, 179:7876-7882.
25. Nunomura S., Endo K., Makishima M., Ra C. Oxysterol represses high-affinity IgE receptor-stimulated mast cell activation in liver X receptor-dependent and -independent manners. FEBS Lett. 2010, 584:1143-1148.
26. Paruchuri S., Jiang Y., Feng C., Francis S.A., Plutzky J., Boyce J.A. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. J. Biol. Chem. 2008, 283:16477-16487.
27. Pei L., Castrillo A., Chen M., Hoffmann A., Tontonoz P. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J. Biol. Chem. 2005, 280:29256-29262.
28. Pei L., Castrillo A., Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol. Endocrinol. 2006, 20:786-794.
29. Pei L., Waki H., Vaitheesvaran B., Wilpitz D.C., Kurland I.J., Tontonoz P. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat. Med. 2006, 12:1048-1055.
30. Pekarsky Y., Hallas C., Palamarchuk A., Koval A., Bullrich F., Hirata Y., Bichi R., Letofsky J., Croce C.M. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3690-3694.
31. Pols T.W., Bonta P.I., de Vries C.J. NR4A nuclear orphan receptors: protective in vascular disease?. Curr. Opin. Lipidol. 2007, 18:515-520.
32. Rönnberg E., Guss B., Pejler G. Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response. Infect. Immun. 2010, 78:854-864.
33. Turner H., Kinet J.P. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 1999, 402:B24-30.
34. Wingate A.D., Campbell D.G., Peggie M., Arthur J.S. Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. Biochem. J. 2006, 393:715-724.
35. Woronicz J.D., Calnan B., Ngo V., Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 1994, 367:277-281.
36. Youn H.D., Chatila T.A., Liu J.O. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 2000, 19:4323-4331.
37. Young L.H., Balin B.J., Weis M.T. Go 6983: a fast acting protein kinase C inhibitor that attenuates myocardial ischemia/reperfusion injury. Cardiovasc. Drug Rev. 2005, 23:255-272.
38. Zetterstrom R.H., Williams R., Perlmann T., Olson L. Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Brain Res. Mol. Brain Res. 1996, 41:111-120.